Acasti Pharma Inc. (ACST)
NASDAQ: ACST · IEX Real-Time Price · USD
2.840
-0.030 (-1.05%)
Jul 22, 2024, 9:30 AM EDT - Market open
Acasti Pharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$6.00
Upside
+111.27%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +111.27% | Feb 7, 2024 |
EF Hutton | EF Hutton | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +428.17% | Feb 15, 2023 |
EF Hutton | EF Hutton | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +428.17% | Dec 19, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +407.04% | Dec 15, 2022 |
Oppenheimer | Oppenheimer | Buy Initiates $36 | Buy | Initiates | $36 | +1,167.61% | Dec 22, 2021 |
Oppenheimer | Oppenheimer | Buy Initiates $36 | Buy | Initiates | $36 | +1,167.61% | Dec 21, 2021 |
Aegis Capital | Aegis Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 2, 2020 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 1, 2020 |
B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 1, 2020 |
B. Riley Securities | B. Riley Securities | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Jul 6, 2020 |
Aegis Capital | Aegis Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | May 6, 2020 |